Noradrenergic and neuropeptide Y mechanisms in guanethidine-sympathectomized rats.
The cardiovascular responses to sympathomimetic agents, the norepinephrine (NE) content in peripheral tissues, and the tissue content and cardiovascular effects of neuropeptide Y (NPY) were examined in anesthetized adult rats with guanethidine-induced sympathectomy (GuSx). We observed blunted pressor responses to tyramine, exaggerated pressor responses to phenylephrine, and markedly reduced NE contents in the atrium, femoral artery, superior cervical ganglion (SCG), and sciatic and vagus nerves. When tyramine responses were corrected for the NE content in the SCG, GuSx rats were similar to controls. A depletion of NPY levels in tissue resulted in an increased sensitivity to the pressor effects of intravenous NPY administration. GuSx, therefore, reproduces findings of postganglionic adrenergic failure in humans. Responses to the administration of sympathomimetic agents may reflect the degree of noradrenergic denervation. NPY may be a potential marker of chronic postganglionic sympathetic denervation in cardiovascular tissue.
Benarroch
E E
EE
Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905.
Schmelzer
J D
JD
Ward
K K
KK
Nelson
D K
DK
Low
P A
PA
D000818:Animals; D001696:Biomechanical Phenomena; D001794:Blood Pressure / Q000187:drug effects; D006145:Guanethidine; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D009638:Norepinephrine / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D012146:Rest; D013563:Sympathectomy, Chemical; D013566:Sympathomimetics / Q000494:pharmacology
D009478:Neuropeptide Y; D013566:Sympathomimetics; D009638:Norepinephrine; D006145:Guanethidine